A series of commercially available phenothiazine dyes was explored for their application in aqueous organic redox flow batteries. Of the dyes explored, Azure-A was found to have the most promising cycling performance and highest solubility, which was improved further with the use of nicotinamide as a ‘hydrotrope’ additive, which improved both solubility and cycle life. However, it was found that only ~50 % of theoretical capacity expected for Azure-A redox could be reached, regardless of cycling conditions. Through in situ and ex situ NMR, UV/vis and EPR spectroscopy as well as battery cycling using low-concentrations of the dye, this was ascribed to dimerisation of the redox-active species, which takes place at concentrations greater than 10 mM. Because of this, Azure-A is, in effect, only capable of a net 1e− redox process under practical conditions. By combining novel electrochemical impedance spectroscopy processing methods (including distribution of relaxation times and general phase element analysis) with symmetric cell cycling, a degradation mechanism involving polymerisation and passivation of the electrode is proposed as one source of the decrease in capacity with cycling.
Grey et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: